求人名 Early Scientific Engagement and Communication Lead
勤務地 Nihonbashi, Tokyo
事業部 Clinical Operations, Quantitative Sciences and China Development
雇用形態 正社員
仕事内容
【募集の背景 / Purpose & Scope】
Early Scientific Engagement & Communications Lead will support the strategic development and execution of scientific communications for oncology-focused early-stage assets, ensuring alignment with the broader global oncology portfolio strategy. Reporting to the Head of Early Scientific Engagement and Communications, this Japan-based role is positioned within the Quantitative Sciences & Evidence Generation (QSEQ) function. This enables a data-driven, evidence-backed approach that integrates biostatistics, real-world evidence (RWE), epidemiology, and medical writing to shape compelling scientific narratives for oncology research assets originating from or relevant to the Japan region.
A core focus of this role is to support the initiation of scientific narratives for oncology assets beginning at the discovery and pre-clinical stages, working closely with Japan Oncology Research and Development leads. The role will leverage existing global Scientific Platforms and processes to ensure regional activities are aligned with global strategies. This position will be instrumental in driving early data dissemination within the Japan context, providing tactical support to global and regional Asset Maximization Teams (AMTs) to ensure the early-phase oncology portfolio is positioned effectively for regional needs. Collaboration with Japan Corporate Communications and regional leadership will be essential to align external messaging for early-stage assets with global strategy.
This role will work in close partnership with global and regional Scientific Publications teams, ensuring that the scientific communication strategy for early-stage oncology assets is seamlessly integrated within the broader pipeline strategy and adapted for regional scientific discourse.
【職務の内容 / Essential Job Responsibilities】
（雇入れ直後）
Oncology Research-Focused Scientific Engagement & Strategic Communications (Japan Support)
・Support the development of scientific narratives for early-stage oncology assets in partnership with Japan and global Oncology Research leads, ensuring alignment with the broader global scientific strategy and corporate narrative.
・Execute strategic scientific messaging for oncology assets from drug discovery through Proof of Concept (POC), with a focus on relevance for the Japan research environment and scientific community.
・Provide tactical support to global and regional AMTs on early data dissemination plans, ensuring alignment with asset development and communication strategies for the Japan region.
・Partner with Japan Corporate Communications to integrate early-stage scientific messaging into regional external engagement strategies, ensuring alignment with global guidance.
・Collaborate with global and regional Scientific Publications teams to align on scientific communication platforms, ensuring a unified strategy for the early oncology pipeline.
・Support the integration of early-phase scientific communication with data-driven insights by liaising with QSEQ’s biostatistics, RWE, and epidemiology teams to contribute to evidence-backed communication materials.
Oncology Early Pipeline Publications & Content Strategy (Regional Execution)
・Support the implementation of global publication plans to ensure early-phase oncology assets are strategically positioned in regional and global scientific discourse.
・Assist in developing and executing publication strategies in collaboration with Subject Matter Experts (SMEs) within Japan R&D for early-phase pipeline publications.
・Leverage established global scientific platforms to enhance publications and optimize content for potential re-use in regional contexts.
・Ensure regional publication activities align with evolving scientific data and global early clinical development priorities.
Content Development & Scientific Communications Support
・Develop and adapt centralized scientific content for early-phase oncology assets to support regional Medical Information and Medical Education functions in Japan.
・Support Japan Medical Information content review for early pipeline scientific accuracy and consistency.
・Assist in guiding digital publication enhancements and publication extenders for early-phase oncology assets in the region.
Cross-Functional Collaboration & Stakeholder Engagement
・Ensure close collaboration with Japan and global Scientific Publications teams while maintaining a distinct focus on early-stage asset communications.
・Engage with Japan clinical, regulatory, and research teams to ensure that early-phase scientific insights are strategically communicated and aligned across functions.
・Represent the Japan early scientific engagement activities in internal discussions, contributing to strategic alignment between regional and global pipeline development efforts.
This position reports to an Executive Director.
This position is an individual contributor role.
This position is a hybrid position.
This position is part of the Quantitative Sciences and Evidence Generations group. Cell and Gene Therapy & Biopharma, or Exploratory statistics in SRS.
（変更の範囲）
会社内での全ての業務
【就業環境に関する要件 / Specific Physical or Environmental Requirements】
At Astellas we recognize the importance of work/life balance, and we are proud to offer a hybrid working solution allowing time to connect with colleagues at the office with the flexibility to also work from home. We believe this will optimize the most productive work environment for all employees to succeed and deliver. Hybrid work from certain locations may be permitted in accordance with Astellas’ Responsible Flexibility Guidelines.
【応募要件 / Qualifications】
＜必須 / Required＞
・Advanced degree (MS, PhD, PharmD, or MD) in Life Sciences, Oncology, or a related field.
・5+ years of experience in scientific communications, medical affairs, publications, or a related role within the pharmaceutical or biotech industry, with a focus on oncology.
・Experience in early-phase drug development and scientific engagement, preferably within a Japan or global context.
・Understanding of publication planning and execution, particularly for early-stage assets.
・Proven ability to collaborate effectively with cross-functional teams, including research, clinical development, and communications.
・Excellent scientific writing, presentation, and stakeholder engagement skills in both Japanese and English.
・Strong organizational and project management skills, with the ability to manage multiple priorities.
・Ability to translate complex scientific data into clear and impactful communication materials.
＜歓迎 / Preferred＞
・8+ years of relevant experience in oncology-focused scientific communications.
・Experience working in a global matrix organization and navigating regional/global dynamics.
・Experience supporting or working with research teams in a discovery or translational science setting.
・Familiarity with the Japan pharmaceutical industry landscape and key scientific audiences.
・Flexibility to travel domestically and internationally as needed.
This Japan-based role is critical for ensuring regional scientific insights are integrated into the global narrative for Astellas’ early oncology pipeline, enabling effective, evidence-backed communication that supports value creation in the Japan market and beyond.
【応募書類 / Application Documents】
和文履歴書・和文職務経歴書・英文レジュメ
Both Japanese and English Resumes are needed
【選考プロセス / Selection details】
書類選考 → 1次面接 →最終面接
※変更の可能性もございますので、予めご了承下さい。
CV screening → First interview → Final interview
*Please be advised that there might be a change in the process.
【勤務地 / Location】
（雇入れ直後）
東京都中央区 アステラス製薬 日本橋事業所 本社
Nihonbashi, Tokyo
（変更の範囲）
会社の定める事業場および自宅
【勤務開始日 / Start Date】
応相談
Will be decided according to the candidate's flexibility
【契約期間 / Contract Duration】
期間の定めなし
Not limited to specified period
【試用期間 / Probation Period】
試用期間原則なし
No probation period in principle
【給与 / Salary】
①基本給：当人の経歴・技術・技能等を考慮して決定
②裁量労働制の場合：裁量労働手当として職務グレードに応じて50,000～100,000円支給
③フレックスタイム制の場合：月間の所定労働時間を超えて勤務する時間に対して時間外勤務手当を支給
①Base salary: will be decided by the candidate's experience, skill and capability.
②When Discretionary Work System is applied: Discretionary work allowance will be paid.(50,000～100,000yen, based on the Grade)
③When Flextime System is applied: Overtime allowance will be paid for time worked in excess of prescribed working hours.
【昇給 / Salary Raise】
有り
【賞与 / Bonus】
有り
【諸手当 / Allowance】
裁量労働手当、住宅手当、通勤手当 等
Discretionary work allowance, Housing allowance, Commutation allowance, etc.
【勤務時間 / Working Hours】
8:45～17:45（月～木）、8:45～16:00（金）
裁量労働制の場合、所定労働時間を働いたものとみなす
8:45～17:45（Mon～Thu）、8:45～16:00（Fri）
Discretionary Work System
【休日 / Holidays】
完全週休２日制（土曜・日曜）、祝日、5月1日、夏季、年末年始
Weekends(Sat and Sun), holidays, May 1st, summer vacation, New Year holidays
【休暇 / Vacation Leave】
年次有給休暇、育児休業制度、介護休業制度 等
Annual paid leave, childcare leave system, nursing care leave system, etc.
【福利厚生 / Welfare】
雇用保険、労災保険、厚生年金、健康保険、共済会制度、社宅制度、持株会制度、財形貯蓄制度 等
Employment Insurance, Industrial Accident Compensation Insurance, Welfare Pension Insurance, Health Insurance, Mutual Aid Association System, Company Housing System, Employee Shareholder Association System, Property Accumulation Savings System
【アステラス製薬 採用サイト/ Career web site】
https://re-jp.astellas.com/jp/recruit/newgraduates/
For more information about Astellas, please visit our career web site.
"We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law."